Physician profile
Scott Achramowicz
NPI 1295244630
$335.24
in general payments reported to CMS, 2019-2025
12 companies · $47.12 in 2025
The $47.12 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $136 · 2022: $36.35 · 2023: $61.61 · 2024: $53.94 · 2025: $47.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $60.59 | 2023-2024 | Dalvance |
| Janssen Pharmaceuticals, INC | $54.51 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $45.05 | 2021 | |
| Boston Scientific Corporation | $29.04 | 2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.94 | 2021 | |
| Pfizer INC. | $22.03 | 2024 | |
| Glaxosmithkline, LLC. | $20.46 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $18.08 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.50 | 2021 | |
| Bioxcel Therapeutics, INC. | $16.91 | 2023 | Igalmi |
| Alexion Pharmaceuticals, INC. | $16.02 | 2023 | Soliris |
| E.R. Squibb & Sons, L.L.C. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Achramowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.